GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/IBD/Diagnostic performance of intestinal ultrasound compared with CT enterography in Crohn’s disease: single-center experience
87

Diagnostic performance of intestinal ultrasound compared with CT enterography in Crohn’s disease: single-center experience

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated December 1, 2025

The study conducted a retrospective single-center analysis to evaluate the diagnostic performance of transabdominal bowel ultrasonography (TBUS) compared with computed tomography enterography (CTE) in identifying intestinal lesions and complications in patients with Crohn’s disease (CD). Crohn’s disease is a chronic inflammatory condition that can affect any part of the gastrointestinal tract and is often associated with complications such as intestinal wall thickening, stenosis, fistulas, and abdominal abscesses. Accurate imaging is critical for diagnosis, monitoring, and long-term follow-up in these patients.

Key Findings:

  1. Diagnostic Accuracy of TBUS vs. CTE:
  • TBUS demonstrated comparable diagnostic accuracy to CTE for detecting diseased bowel segments, intestinal wall abnormalities, and complications such as stenosis, fistulas, and abdominal abscesses.
  • TBUS effectively visualized bowel wall thickness, layered structure, vascular changes, and extraintestinal complications.
  • Diagnostic interpretations of TBUS showed strong consistency between different observers, indicating its reliability.
  1. Postoperative Assessment:
  • TBUS remained effective in patients who had undergone prior intestinal surgery, highlighting its utility in postoperative follow-up.
  1. Advantages of TBUS:
  • Non-invasive: TBUS does not require radiation exposure, making it safer than CTE, particularly for long-term disease monitoring.
  • Repeatable: TBUS can be performed frequently without concerns about radiation or invasive procedures.
  • Practical for Long-Term Monitoring: TBUS is well-suited for ongoing assessment and follow-up, as it can detect disease progression and complications over time.
  • Extraintestinal Complications: TBUS showed strengths in identifying complications outside the intestine, which may guide clinical decision-making.
  1. Clinical Utility:
  • TBUS proved to be a valuable imaging tool for routine practice and long-term disease management in Crohn’s disease patients.
  • Its ability to provide detailed imaging without the risks associated with CTE makes it an attractive option for clinicians.

Conclusion:

The study concludes that transabdominal bowel ultrasonography is a highly useful diagnostic tool for Crohn’s disease, offering performance comparable to CT enterography while providing significant advantages in safety, flexibility, and practicality. TBUS is especially beneficial for long-term monitoring, postoperative follow-up, and identifying extraintestinal complications, making it a preferred imaging modality in routine clinical practice for Crohn’s disease management.

Related Q&A

88

Efficacy and safety of IL-23 inhibitors in the treatment of moderate to severe UC

The meta-analysis conducted on randomized controlled trials provides comprehensive insights into the efficacy and safety of IL-23 inhibitors for the treatment of moderate to severe ulcerative colitis (UC)....

89

Upadacitinib in a real-world data from UK

The real-world data on the use of upadacitinib for Crohn’s disease (CD) in the UK provides valuable insights into its effectiveness and safety in a challenging, clinically refractory...

90

single-wavelength endoscopy technology in UC

Single-wavelength endoscopy (SWE) is an advanced imaging technology that uses light of a specific wavelength to enhance visualization of tissue characteristics during endoscopic procedures. In the context of...

91

ESD for high-risk colorectal colitis-associated neoplasia in IBD

Endoscopic submucosal dissection (ESD) has emerged as a highly effective and safe treatment for high-risk colorectal colitis-associated neoplasia (HR-CAN) in patients with inflammatory bowel disease (IBD), according to...

92

A Consensus Blueprint for Steroid Stewardship in IBD Trials

The "Consensus Blueprint for Steroid Stewardship in IBD Trials" is a globally agreed-upon framework developed by a panel of 45 international experts through the Delphi process to standardize...

93

Noninvasive Imaging in and IBD

Noninvasive imaging techniques are revolutionizing the diagnosis, monitoring, and management of inflammatory bowel disease (IBD), which includes conditions like Crohn’s disease (CD) and ulcerative colitis (UC). These methods...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer